UK Myeloma Society – Bursary Opportunity

Dear BOPA members,

The BOPA Research Subcommittee would like to share with members the following bursary opportunity.

The UK Myeloma Society is pleased to announce that 2 travel grants of up to £900 each are available to scientists, clinicians, nurses and pharmacists who wish to attend the EHA Congress on 13-16 June 2026 in Madrid.

How to apply?

Please click here to download information for the entry criteria and how to apply. This information can also be found by following the link to our website.

• Entrants must be a member of the UKMS. This is free and easy to do.
• Applicants must be either the first or last author. Or, if neither, please specifically state your substantial contribution to this work to justify the bursary.
• Applicants will be asked to indicate whether they would attend virtually or in person and the amount awarded will reflect this.
• Those who have been awarded a UKMS (formally UKMF) travel bursary in the last 2 years are not eligible to apply.

If you have any queries, or are unable to download the information sheet, please do not hesitate to contact [email protected]. 

To be considered for a UKMS travel bursary, the deadline to submit an abstract will be 5pm on Friday 1 March 2024. Winners to be announced by the end of March 2024.

Thank you to the UKMS Premium sponsors, Menarini Stemline and Sanofi for supporting a joint UKMS bursary. We are also thankful to the trustees of the Michael Morley Fund for their continued support.

Kind regards,

BOPA Research subcommittee

on behalf of

The UK Myeloma Society

Latest News

By Mohammed Patel on 11th November 2026

UK BMT Pharmacists Group Educational Meeting – Friday 13th November 2026. Time:14:00 to 16:00

The next UK BMT Pharmacists Group Educational Meeting is on Friday 13th November, 2pm–4pm. The sessions include: Maintenance Therapy for AML After Allogeneic BMT with Dr Mili Shah, Consultant Haematologist,…

Read article
By UK SACT Board on 9th November 2026

New UK SACT Board National Intrathecal and Intraventricular SACT Guidance

Dear colleagues, We are pleased to share the newly published UK SACT Board National Guidance on the Safe Administration of Systemic Anti-Cancer Therapies via the Intrathecal or Intraventricular Routes. This…

Read article
By BOPA Executive Committee on 9th November 2026

BOPA members flying the flag for cancer pharmacy at ESMO 2026

It was fantastic to see BOPA members representing cancer pharmacy at ESMO Congress 2026 in Madrid, which brought together the global cancer community from 23 to 27 October to share…

Read article
By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article